Huvepharma® is a fast-growing global pharmaceutical company with a focus on developing, manufacturing and marketing of human and animal health products.

Huvepharma entered the market of veterinary products for farm animals in 2000, after it acquired the majority stake in Biovet (Bulgaria).

With its extensive production facilities, Biovet was one of the largest manufacturers of medical and preventive remedies in Europe since its founding in 1954.

After joining Huvepharma®, significant investments were made in the modernization and development of existing facilities as well as in the acquisition of new R&D facilities.

The Moscow representative office of HUVEPHARMA JSC was opened in 2008.

The main activities of the company are laid down in the name “HUVEFARMA” – HUman and VEterinarian PHARMAceuticals. The company’s products are registered and sold in more than 60 countries of the world.

Currently, the company is focused on the development, implementation and production of highly effective pharmaceuticals used to treat and improve the animal productivity. New products, which are already highly demanded in Europe, the USA and Asian countries, are in the process of registration and launching in the domestic market. Currently, a lot of products for the poultry, swine and cattle industry received the state registration in Russia.